Patient P-01683

Synthetic patientNBL-101 · Day 120 · 35–44 · F · baseline S13Steering view · 3D Open companion preview

Therapy response

Favorable

Tolerance

Deteriorating

GI state

Improving

Inflammatory state

Favorable

Nutritional resilience

Improving

Discontinuation risk

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 NBL-101 started — Baseline state S13

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

Toxicity+7
Nutritional resilience+6
GI instability-5
Treatment adherence-4
Inflammatory activity+3

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden

Companion

9.7/100

improving · -9.5 vs previous 14 d

Toxicity

Blood

18.5/100

improving · -1.0 vs previous 14 d

Sleep quality

Wearable

58.7/100

improving · +4.6 vs previous 14 d

Energy level

Daily log

7.6/10

improving · +0.6 vs previous 14 d

Stress level

Daily log

3.6/10

improving · -0.8 vs previous 14 d

Steps

Wearable

10,221

improving · +460 vs previous 14 d

Adherence

Companion

90 %

stable · +3.3 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 94 from the failing basin, 10 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.

Would not help

Keep fibre low
GI +1.8 next day on high-intake days · n 18

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Insoluble fibre
+1.8detractor · 56%
Histamine load
+1.1no signal · 35%
Alcohol
-0.7no signal · 20%
Dietary fat load
+0.3no signal · 15%
Spicy / capsaicin
+0.3no signal · 15%
Simple carbohydrates
-0.1no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Drug metabolism and exposure ↑40
- DNACYP2D6 poor metabolizer → higher exposure
Inflammatory signalling ↑15
- WearableHRV 34 ms, trending down

DNA

Fictional pharmacogenomic panel

CYP2D6 Poor metabolizer
Higher exposure at standard dose

Microbiome

Shannon diversity 3.2 · butyrate capacity 46/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisNormal
Bifidobacterium longumLow
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 36 ms
Sleep: 7.3 h
Steps: 10,052
Resting HR: 65 bpm

Daily log: GI score 10, nutritional resilience 68, adherence 90.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-01766	41%	S05	AD-05	no change	90
P-01804	30%	S19	AD-05	improved	61
P-01495	51%	S07	BR-03	improved	85
P-01329	45%	S08	BR-03	improved	79
P-01677	37%	S05	BR-03	no change	86
P-01654	52%	S08	CR-01	improved	85
P-01430	26%	S05	CR-01	improved	54
P-01479	37%	S15	DT-01	improved	84
P-01855	33%	S04	DT-01	improved	73
P-01767	31%	S14	DT-01	no change	63
P-01724	29%	S10	DT-01	improved	63
P-01346	27%	S12	DT-01	improved	52